Evidence map›Paper›PMID 40064965›Full record

ArticleNature communications2025

Kallikrein-8 mediates furin-independent Activin-A precursor processing to stimulate tumor growth in melanoma.

Manon Bulliard, Katarina Pinjusic, Laura Iacobucci, Céline Schmuziger, Nadine Fournier, Daniel B Constam

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manon BulliardÉcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, 1015, Lausanne, Switzerland.ORCID http://orcid.org/0009-0009-2292-7046
Katarina PinjusicÉcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, 1015, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-5070-3340
Laura IacobucciÉcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, 1015, Lausanne, Switzerland.
Céline SchmuzigerÉcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, 1015, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-7482-7105
Nadine FournierÉcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, 1015, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-9347-7929
Daniel B ConstamÉcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, 1015, Lausanne, Switzerland. Daniel.Constam@epfl.ch.ORCID http://orcid.org/0000-0002-6256-3891

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 31003A_179330
6 · The paper itself

Abstract

Receptor binding of TGF-β and related ligands such as Activin-A requires cleavage of a furin site in their dimeric precursor proteins. Melanoma cells cleave one Activin-A subunit independently of furin and related proprotein convertases, raising questions of how this half-processed intermediate is generated and whether it influences tumor growth. Here, an siRNA library screen for proteases mediating this furin-independent "hemicleavage" identifies kallikrein (Klk)-8. While a KLK8 cleavage site in proActivin-A overlaps with the furin recognition sequence, its exposure is limited and requires prior transient acidification. Therefore, only furin efficiently converts proActivin-A to fully mature form both in tumor cells and in cell-free cleavage assays. Moreover, knockdown of Klk8 in syngeneic melanoma grafts suppresses Activin-A induced tumor growth, demonstrating that cleavage by only furin is not sufficient. Besides elucidating how Activin-A processing is regulated, our findings show that KLK8 holds promise as a target to mitigate Activin-A induced tumor growth.

Indexed as

ActivinsFurinKallikreinsMelanomaProtein PrecursorsAnimalsCell Line, TumorFemaleHumansMiceMice, Inbred C57BLRNA, Small Interferingactivin AActivinsFurinFURIN protein, humanKallikreinsKLK8 protein, humanProtein PrecursorsRNA, Small Interfering

Identifiers

PMID40064965
PMCPMC11893775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.